This federal contract award, with a ceiling value of $1,332.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of CEFEPIME-DEXTROSE 2 GM/50 MLS, a pharmaceutical product, with a completion date of December 10, 2024. The contract is a Firm Fixed Price arrangement and was not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Generated 3/10/25, 9:50 AM